Embracing Future Holdings Limited (SGX:8YY)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0520
+0.0010 (1.96%)
At close: Mar 20, 2026
Market Cap90.14M +97.5%
Revenue (ttm)5.26M +513.2%
Net Income-3.96M
EPS-0.00
Shares Out1.73B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,323,000
Average Volume9,863,490
Open0.0510
Previous Close0.0510
Day's Range0.0510 - 0.0530
52-Week Range0.0160 - 0.0920
Beta0.63
RSI43.64
Earnings DateFeb 28, 2026

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 b... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 7
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 8YY
Full Company Profile

Financial Performance

In 2025, Embracing Future Holdings's revenue was 5.26 million, an increase of 513.17% compared to the previous year's 858,000. Losses were -3.96 million, 15.4% more than in 2024.

Financial Statements